Martin A. Lehr
Chief Executive Officer, Director · Context Therapeutics Inc.
Individual
- 2026
- Feb 23, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Martin A. Lehr's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Martin A. Lehr?
Martin A. Lehr is a corporate insider, tracked as Chief Executive Officer, Director of Context Therapeutics Inc. (CNTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Martin A. Lehr last file a Form 4?
The only primary Form 4 on record is dated 23 February 2026.